CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-13 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,744 | $143.04 | $249K | 148,811 |
| 2017-10-13 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −11,384 | 0 | ||
| 2017-09-05 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion | +5,000 | $21.00 | $105K | 144,171 |
| 2017-09-05 | HIGGINS JOHN L Chief Executive Officer | Sale | −5,000 | $130.00 | $650K | 139,171 |
| 2017-09-05 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −5,000 | 0 | ||
| 2017-08-23 | Aryeh Jason Director | Sale | −2,000 | $127.99 | $256K | 114,651 |
| 2017-08-18 | Gray Nancy Ryan Director | Grant or award | +913 | 913 | ||
| 2017-08-18 | Gray Nancy Ryan Director | Grant or award · Common Stock | +3,452 | 3,452 | ||
| 2017-08-09 | FOEHR MATTHEW W President and COO | Exercise or conversion | +6,100 | $9.97 | $61K | 101,020 |
| 2017-08-09 | FOEHR MATTHEW W President and COO | Sale | −6,100 | $127.51 | $778K | 94,920 |
| 2017-08-09 | FOEHR MATTHEW W President and COO | Exercise or conversion | +850 | $9.97 | $8K | 95,770 |
| 2017-08-09 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −6,100 | 43,935 | ||
| 2017-08-09 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −850 | 43,085 | ||
| 2017-08-09 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −18,625 | $126.96 | $2.4M | 24,423 |
| 2017-08-08 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion | +5,483 | $21.00 | $115K | 144,654 |
| 2017-08-08 | HIGGINS JOHN L Chief Executive Officer | Sale | −5,483 | $125.00 | $685K | 139,171 |
| 2017-08-08 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −5,483 | 5,000 | ||
| 2017-08-06 | Korenberg Matthew E VP, Finance and CFO | Shares withheld for taxes | −609 | $122.06 | $74K | 14,706 |
| 2017-06-30 | Berkman Charles S VP, Gen. Counsel & Secretary | Other acquisition | +243 | $87.13 | $21K | 43,048 |
| 2017-06-30 | Korenberg Matthew E VP, Finance and CFO | Other acquisition | +243 | $87.13 | $21K | 15,315 |
Page 56 of 86 · 1,712 trades